You just read:

Apexigen Announces Late-Breaking Oral Presentation for Immune Activating Antibody APX005M at the 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting

News provided by

Apexigen, Inc.

Oct 31, 2017, 07:00 ET